ArticleJournal of hepatocellular carcinoma2022

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment.

Yang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.